<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39422816</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1543-0154</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of cancer education : the official journal of the American Association for Cancer Education</Title><ISOAbbreviation>J Cancer Educ</ISOAbbreviation></Journal><ArticleTitle>Gender Differences on the Awareness of Human Papillomavirus Infection and Vaccination.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13187-024-02516-8</ELocationID><Abstract><AbstractText>Human papillomavirus (HPV) infection is implicated in causing several types of cancer, including cervical cancer. In Brazil, the quadrivalent HPV vaccine is provided free of charge for children between the ages of 9 and 14. Nevertheless, the vaccination coverage rate has remained below 60% since its implementation in 2014. This study aimed (i) to assess the knowledge of parents/guardians on HPV infection and vaccine prophylaxis and (ii) to test the association between having a "higher degree of knowledge" (HDK) and the sociodemographic characteristics. A total of 388 parents/guardians of children of vaccination age were enrolled. Questions assessing sociodemographic characteristics, knowledge, and attitudes toward HPV infection and vaccination were administered to participants via a self-answered questionnaire. Questionnaires of 343 participants were considered for analysis. Participants who answered at least 70% of the questions correctly were classified as presenting HDK. Multivariate logistic regression analysis was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) for the associations between population characteristics and HDK. This study occurred prior to the COVID-19 pandemic; thus, the pandemic was not considered in our analysis. A total of 212 (61.8%) participants showed HDK. Participants who were male (OR = 0.39; 95% CI = 0.22, 0.70) and lived in larger households (OR = 0.48; 95% CI = 0.25, 0.95) were less likely to present HDK. Participants who reported having an acquaintance with prior/concurrent HPV infection were more likely to have HDK (OR = 3.78; 95% CI = 2.02, 7.05). These findings suggest the importance of developing novel strategies for raising parental awareness of HPV, particularly targeting males.</AbstractText><CopyrightInformation>© 2024. The Author(s) under exclusive licence to American Association for Cancer Education.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heimbecker</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Federal University of Paraná, Curitiba, Paraná, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bordini</LastName><ForeName>Santina C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Elementary Education, Curitiba Municipal Department of Education, Curitiba, Paraná, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Ana Carolina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Alencar</LastName><ForeName>Nina M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Nicholas S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitz</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>Gabriela B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Federal University of Paraná, Curitiba, Paraná, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumitru</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercadante</LastName><ForeName>Adriana F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarenga</LastName><ForeName>Larissa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Cristina L B</ForeName><Initials>CLB</Initials><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marconi</LastName><ForeName>Camila</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7742-1186</Identifier><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Federal University of Paraná, Curitiba, Paraná, Brazil. marconi@ufpr.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Pathology, Sector of Biological Sciences, Federal University of Paraná, Av. Cel. Francisco H. Dos Santos, 100, Curitiba, Paraná, 81531-980, Brazil. marconi@ufpr.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cancer Educ</MedlineTA><NlmUniqueID>8610343</NlmUniqueID><ISSNLinking>0885-8195</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescent</Keyword><Keyword MajorTopicYN="N">Awareness</Keyword><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">Human papillomavirus virus</Keyword><Keyword MajorTopicYN="N">Knowledge</Keyword><Keyword MajorTopicYN="N">Vaccines</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39422816</ArticleId><ArticleId IdType="doi">10.1007/s13187-024-02516-8</ArticleId><ArticleId IdType="pii">10.1007/s13187-024-02516-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Herzog R, Álvarez-Pasquin MJ, Díaz C, Barrio JLD, Estrada JM, Gil Á (2013) Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? BMC Public Health, A systematic review. https://doi.org/10.1186/1471-2458-13-154</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-13-154</ArticleId></ArticleIdList></Reference><Reference><Citation>Chido-Amajuoyi OG, Jackson I, Robert Yu, Shete S (2020) Declining awareness of HPV and HPV vaccine within the general US population. Hum Vaccin Immunother. https://doi.org/10.1080/21645515.2020.1783952</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1783952</ArticleId><ArticleId IdType="pubmed">32692632</ArticleId><ArticleId IdType="pmc">7899652</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride, Kimberly R, and Shipra Singh (2018) Predictors of adults’ knowledge and awareness of HPV, HPV-associated cancers, and the HPV vaccine: implications for health education. Health Education and Behavior. https://doi.org/10.1177/1090198117709318 .</Citation></Reference><Reference><Citation>Du EY, Du AB, Taylor DB, Kuziez D, Rohde RL, Pannu JS, Simpson MC, Patterson RH, Varvares MA, Osazuwa-Peters N (2022) Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer. Hum Vaccin Immunother. https://doi.org/10.1080/21645515.2022.2109892</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2109892</ArticleId><ArticleId IdType="pubmed">36412232</ArticleId><ArticleId IdType="pmc">9746550</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira GR, Formigosa JA, Lira AL, Reis RK, Gir E, Freitas WL, Carvalho JN, Gonçalves LH, Botelho EP, Ramos AM (2022) The family health strategy influence on the human papillomavirus vaccine acceptance in a peripheral community of the Brazilian Amazon region. Health Equity. https://doi.org/10.1089/heq.2022.0009 .</Citation></Reference><Reference><Citation>WHO, World Health Organization (2009) Human papillomavirus vaccines WHO position paper. Vaccine. https://doi.org/10.1016/j.vaccine.2014.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>BRASIL, Ministério da Saúde (2013) Informe técnico da vacina papilomavírus humano (HPV) na Atenção Básica. http://www.riocomsaude.rj.gov.br/Publico/MostrarArquivo.aspx?C=2m3JjlW6qoI%3D . Accessed 02 February 2024.</Citation></Reference><Reference><Citation>BRASIL, Ministério da Saúde (2017) Nota informativa nº 154, de 2017/CGPNI/DEVIT/SVS/MS. Ampliação da faixa etária de 11 a 14 anos para meninos com a vacina HPV quadrivalente. https://sbim.org.br/images/files/nota-informativa-154-ms.pdf . Accessed 02 February 2024.</Citation></Reference><Reference><Citation>BRASIL, Ministério da Saúde (2015) Informe técnico da vacina papilomavírus humano 6, 11, 16 e 18 (recombinante). https://saude.es.gov.br/Media/sesa/PEI/Informe_Tecnico_vacina_papilomavirus_humano_6_11_16_18_recombinante_agosto_2015.pdf . Accessed 02 February 2024.</Citation></Reference><Reference><Citation>BRASIL, Ministério da Saúde (2023) Informações de Saúde (TABNET) – DATASUS. https://datasus.saude.gov.br/informacoes-de-saude-tabnet/ . Accessed 02 February 2024.</Citation></Reference><Reference><Citation>BRASIL, Ministério da Saúde (2023) TabNet Win32 3.0: Projeção da População do Brasil por sexo e idade simples: 2000–2060 (edição 2013). http://tabnet.datasus.gov.br/cgi/deftohtm.exe?ibge/cnv/projpopbr.def . Accessed 02 February 2024.</Citation></Reference><Reference><Citation>Kepka D, Bodson J, Lai D, Sanchez-Birkhead AC, Davis FA, Lee D, Tavake-Pasi F, Napia E, Villalta J, Mukundente V, Mooney R, Coulter H, Stark LA (2021) Diverse caregivers’ HPV vaccine-related awareness and knowledge. Ethn Health. https://doi.org/10.1080/13557858.2018.1562052</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13557858.2018.1562052</ArticleId><ArticleId IdType="pubmed">30589389</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos AC, da Silva N, Silva NT, Carneiro CM, Coura-Vital W, Lima AA (2020) Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians. BMC Public Health. https://doi.org/10.1186/s12889-020-8410-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-8410-9</ArticleId><ArticleId IdType="pubmed">32917178</ArticleId><ArticleId IdType="pmc">7488766</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes Lobão W, Duarte FG, Burns JD, de Souza Teles Santos CA, Chagas de Almeida MC, Reingold A, Duarte Moreira E (2018) Low coverage of HPV vaccination in the national immunization programme in Brazil: parental vaccine refusal or barriers in health-service based vaccine delivery? PLoS ONE. https://doi.org/10.1371/journal.pone.0206726 .</Citation></Reference><Reference><Citation>Martins, Fran, Maiana Diniz (2023) Queda da cobertura vacinal contra o HPV representa risco de aumento de casos de cânceres evitáveis no Brasil. https://www.gov.br/saude/pt-br/assuntos/noticias/2023/fevereiro/queda-da-cobertura-vacinal-contra-o-hpv-representa-risco-de-aumento-de-casos-de-canceres-evitaveis-no-brasil . Acessed 29 September 2024</Citation></Reference><Reference><Citation>Osis MJD, Duarte GA and Sousa MHD (2014) SUS users’ knowledge of and attitude to HPV virus and vaccines available in Brazil. Revista de Saúde Publica. https://doi.org/10.1590/S0034-8910.2014048005026 https://doi.org/10.1590/S0034-8910.2014048005026 .</Citation></Reference><Reference><Citation>Viegas SM, Pereira PL, Pimenta AM, Lanza FM, de Oliveira PP, de Oliveira VC (2019) Preciso mesmo tomar vacina? Informação e conhecimento de adolescentes sobre vacinasa. Avances En Enfermería. https://doi.org/10.15446/av.enferm.v37n2.76713 .</Citation></Reference><Reference><Citation>Kim N, Anneser E, Chu MT, Nguyen KH, Stopka TJ, Corlin L (2023) Household conditions, COVID-19, and equity: insight from two nationally representative surveys. Research Square. https://doi.org/10.21203/rs.3.rs-3129530/v1 .</Citation></Reference><Reference><Citation>WHO, World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 . Accessed 02 February 2024.</Citation></Reference><Reference><Citation>Bono SA, Faria de Moura Villela E, Siau CS, Chen WS, Pengpid S, Hasan MT, Sessou P, Ditekemena JD, Amodan BO, Hosseinipour MC, Dolo H, Joseph Nelson Siewe Fodjo, Wah Yun Low, and Robert Colebunders (2021) Factors affecting COVID-19 vaccine acceptance: an international survey among low-and middle-income countries. Vaccines. https://doi.org/10.3390/vaccines9050515 .</Citation></Reference><Reference><Citation>BRASIL, Ministério da Saúde (2022) Saúde amplia vacinação contra meningite e HPV; entenda o que muda. https://www.gov.br/pt-br/noticias/saude-e-vigilancia-sanitaria/2022/09/saude-amplia-vacinacao-contra-meningite-e-hpv-entenda-o-que-muda . Accessed 02 February 2024.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>